Expanding its Portfolio with American Amnionto Serve the Wound Care Needs of Our Veterans BioStem Technologies launched two new placental-derived allografts—American Amnion and American Amnion
— Submission covers multiple indications including general, urological, colorectal, gynecological and cardiac surgeries — SS Innovations has officially submitted a 510(k) application to the U.S.
BROOMFIELD, Colo., December 2, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW),
Junction Brain Health has opened a new clinic in Toledo, expanding access to advanced, non-invasive treatments for depression across Northwest Ohio and Southeast Michigan. The
Florida Medicaid Adds BioStem’s VENDAJEⓇ and VENDAJE ACⓇ to Covered Skin Substitutes List Key Takeaways POMPANO BEACH, Fla., Nov. 25, 2025 – PRISM MediaWire (Press Release
Compact New Console Facilitates Performance of Telesurgeries from a Wide Range of Locations, including Physicians’ Offices Key Takeaways Historic First for Robotic TelesurgerySS Innovations (Nasdaq:
Key Takeaways POMPANO BEACH, Fla., November 5, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies, Inc. (OTC: BSEM), a
Future Relocation and Expansion to Create Up to 100 New Jobs Over 5 Years City Approves Up to $300,000 in Economic Incentives to Rapidly Growing
Broomfield, CO, November 5, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW),
PRISM MediaWire
info@prismmediawire.com
Phone: 646-780-8850
